Moxetumomab Pasudotox-tdfk and Numorphan
Determining the interaction of Moxetumomab Pasudotox-tdfk and Numorphan and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: moxetumomab pasudotox
Brand name: Lumoxiti
Synonyms: Moxetumomab pasudotox, Moxetumomab Pasudotox
Generic Name: oxymorphone
Brand name: Opana, Opana ER, Numorphan HCl
Synonyms: Numorphan (Injection)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Moxetumomab Pasudotox-tdfk-NuOx
- Moxetumomab Pasudotox-tdfk-Nupercainal
- Moxetumomab Pasudotox-tdfk-Nupercainal HC
- Moxetumomab Pasudotox-tdfk-Nuplazid
- Moxetumomab Pasudotox-tdfk-Nuplazid (Pimavanserin Capsules)
- Moxetumomab Pasudotox-tdfk-Nuplazid (Pimavanserin Tablets)
- Numorphan-Moxetumomab pasudotox-tdfk Intravenous
- Numorphan-Moxifloxacin
- Numorphan-Moxifloxacin (Systemic)
- Numorphan-Moxifloxacin Hydrochloride
- Numorphan-Moxifloxacin Injection
- Numorphan-Moxifloxacin Intravenous